Biofarm, (stock symbol BIO), one of the most important drug manufacturers in Romania, ended 2023 with a net profit of about 77 million lei, up 9% from the previous year and a turnover of approx. 280 million lei, according to preliminary results (unaudited).
"In 2023, we successfully implemented cost optimization strategies, focusing in particular on two of our company values: performance and end-consumer care. In doing so, we were able to identify effective ways to control our expenses, even in the context of rising raw material and packaging prices. The Consumer Healthcare category in Romania is becoming more and more competitive year by year, marked also by a slight decline in volumes in 2023 compared to 2022. However, we ended 2023 managing to consolidate our position on the market, with a positive evolution of the volume market share and to contribute positively on the quality of life of patients and consumers in Romania", said Cătălin Vicol, Biofarm CEO.
Biofarm continued to strengthen its market share in the Consumer Healthcare (CHC) segment, and ended 2023 in second position in terms of number of units sold.
The company dominates in value in 6 key categories across brands: Bixtonim, Triferment, Colebil, Extravalerianic, Carmol and Carbocit. In addition, Biofarm is the volume leader in no less than 8 categories, highlighting the outstanding performance of the brands Bixtonim, Colebil, Triferment, Sennalax, Extravalerianic, Carmol, Carbocit and Nervocalmin. These results confirm the success of Biofarm's approach and commitment to innovation. Through its achievements, the company continues to establish itself as a trusted player in Consumer Healthcare, offering effective and affordable solutions to consumers.
Biofarm has two drug factories in Bucharest and a product testing and development unit, and its portfolio of over 100 products covers the most important therapeutic areas of the Consumer Healthcare division (digestive & metabolic, respiratory & ORL, cardiovascular & circulatory, nervous system). Constant innovation in the development of new products is one of the fundamental elements for Biofarm's expansion and strengthening its position among the leaders in the pharmaceutical industry.
The information provided by KomuniK
On October 30, 2025, Envisia will host the 3rd edition of the Future of Boards Gala. The event brings together board members, executives, and governance ecosystem partners for an evening dedicated to recognizing responsible leadership, corporate governance, and high-performing boards. The six award categories celebrate individuals and boards who, through courageous decisions and integrity, create […]
The European real estate debt market is showing clear signs of recovery, supported by stabilized interest rates, competitive lending, and renewed investor confidence. According to AEW’s latest research, the credit financing gap across Europe is narrowing, with improved lending conditions helping to ease refinancing pressures that have weighed on the sector in recent years. Between […]
French retail chain Carrefour may want to sell its stores in Romania and exit the market, according to the French publication L’Informe. Moreover, it would also like to get rid of its operations in Poland and Argentina, according to the same source. So far, Carrefour has reportedly only analyzed a possible exit from the local […]
Romanians are not looking forward to Black Friday with more enthusiasm than last year, according to a recent survey. The main reasons are economic instability and the decline in purchasing power. Around 22% of Romanians say they will not buy anything on Black Friday 2025, and only 15% of Romanians plan to spend more compared […]
Cristina Ghițulică, a faculty member at the Faculty of Chemical Engineering and Biotechnologies (Politehnica Bucharest), was elected as the first woman president of the European Association for Quality Assurance in Higher Education, or ENQA. Ghițulică is the director general of the Romanian Agency for Quality Assurance in Higher Education. She was elected to head ENQA […]
The Bucharest National Opera and the Kinetobebe Association announced “The Dance of Velvet Steps,” a premiere performance for the audience with special needs, on Sunday, November 16. The show consists of a ballet performance adapted and made accessible for children and adults with disabilities. The performance is primarily addressed to children and adults with special […]
